PWP
LABU icon

Pursue Wealth Partners’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Pursue Wealth Partners’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-750
Closed -$88.8K – 96
2023
Q2 		$88.8K Buy
+750
New +$93.5K 0.06% 98
2022
Q4 		– Sell
-525
Closed -$74K – 108
2022
Q3 		$74K Sell
525
-175
-25% -$32.1K 0.05% 108
2022
Q2 		$94K Buy
+700
New +$119K 0.06% 113

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Pursue Wealth Partners's LABU Position: Q3 2023 in Review

Pursue Wealth Partners sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2023, closing a stake of 750 shares — an estimated $88.8K sold.

Pursue Wealth Partners first reported a position in LABU in Q2 2022 and held it in 3 quarters. The position peaked at $94K in Q2 2022. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2023.

  • Pursue Wealth Partners reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2023 after selling out during the quarter.
  • Pursue Wealth Partners sold 750 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2023, an estimated $88.8K.
  • Pursue Wealth Partners first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2022 and held it in 3 quarters.
  • Pursue Wealth Partners's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $94K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2023.

Based on Pursue Wealth Partners's 13F filing for Q3 2023, filed 24 Oct 2023.